A detailed history of Quantamental Technologies LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Quantamental Technologies LLC holds 19,570 shares of ABCL stock, worth $57,731. This represents 0.09% of its overall portfolio holdings.

Number of Shares
19,570
Holding current value
$57,731
% of portfolio
0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$4.6 - $7.95 $90,022 - $155,581
19,570 New
19,570 $90,000
Q3 2022

Nov 14, 2022

SELL
$9.2 - $13.68 $110,179 - $163,831
-11,976 Reduced 49.95%
11,999 $119,000
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $137,137 - $255,333
23,975 New
23,975 $255,000
Q1 2022

May 16, 2022

SELL
$7.46 - $14.14 $90,116 - $170,811
-12,080 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$12.99 - $17.73 $156,919 - $214,178
12,080 New
12,080 $173,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.